Brooks Running said it delivered record-breaking global growth in 2025, reporting a 16% increase in revenue compared with the previous year and extending its streak to nine consecutive years of growth, according to a company press release issued Thursday.
The Seattle-based brand, owned by Berkshire Hathaway, has long been known as the dependable workhorse of the running shoe world, not flashy, not loud, but always on the wall at your local run shop. Now, it’s putting up numbers that are hard to ignore.
“Running continues to gain extraordinary momentum around the world as more people choose movement as part of their approach to health and wellness,” Dan Sheridan, Brooks’ CEO, said in a statement.
China sales surged 245% as Brooks expands internationally
Brooks said its strongest growth came in its Asia Pacific and Latin America (APLA) region, where revenue rose 66% in 2025. Within that, the company reported that China sales jumped 245%, making it one of Brooks’ fastest-growing markets worldwide.
That’s not just “good growth.” That’s “someone check the spreadsheet again” growth.
Brooks credited part of that rise to its increasing visibility at major races, including the Shanghai Marathon. The company said it ranked as the No. 1 international brand among sub-three-hour finishers at the event, one of the largest marathons in China. (If you’re going to win over a market, getting the fast crowd on your side is a pretty efficient strategy.)
https://marathonhandbook.com/jeremy-renners-brooks/Outside of Asia, Brooks also posted strong gains in its more established markets. The company reported 13% growth in North America and 22% growth in Europe, the Middle East and Africa (EMEA).
Brooks said these results contributed to a 14% compound annual growth rate over nearly 25 years, reflecting what it described as a disciplined focus on performance running since 2001. In other words, the slow-and-steady approach is still working, even in an industry obsessed with what’s “new.”
Brooks strengthens its foothold in specialty retail
In the U.S., Brooks said it reached the No. 1 market position in performance running footwear at specialty retail in Q4 of 2025.
That’s a meaningful claim, because specialty running stores are where serious runners still go when they want real advice, not just a shoe box and a receipt. It’s also where brands either become trusted staples, or quietly disappear from the shelves. Brooks, clearly, is not disappearing.
In Europe, Brooks said it outpaced the overall performance running market in key countries.
The company reported that in France, the performance running footwear market grew 14% in 2025, while Brooks grew 22%. In Germany, the market grew 21%, while Brooks grew 28%.
Brooks also said it secured the No. 1 market position in adult performance running footwear priced at €90 and above in Germany in 2025. (Translation: not just the budget buyers, the “yes I will spend €160 on shoes because my knees deserve peace” crowd.)
Core shoe models helped drive growth
Brooks attributed much of its revenue increase to strong sales performance across its core footwear lineup.
The company said 10 Brooks footwear styles posted year-over-year revenue growth of 20% or more in 2025, suggesting its business is being driven by multiple models rather than one runaway hit.
The biggest standout was the Glycerin franchise, one of Brooks’ most popular cushioned trainers. Brooks said the line delivered 33% revenue growth and a 27% increase in unit sales, driven by the launch of its new DNA Tuned midsole foam technology. Revenue growth accelerated even further in the final stretch of the year, with Brooks reporting a 46% year-over-year surge in Q4.
If you’ve been wondering why you suddenly see Glycerins everywhere at races, there’s your answer.
Brooks also pointed to continued demand for the Adrenaline GTS, its long-running stability trainer, which celebrated its 25th anniversary in 2025. The company said the model delivered double-digit full-price growth and remained a top seller. (Because stability shoes may not be exciting, but neither is shin splints.)
Brooks also introduced the Glycerin Flex, which it described as featuring an “industry-first articulated, strategically segmented midsole.” It’s a mouthful, but the goal is simple: keep proving the brand can innovate, not just iterate.
Estimated revenue reaches $1.6 billion
Brooks does not publicly release detailed financial statements, but outside industry estimates suggest its growth has pushed the company into a higher revenue tier.
In a separate report published Thursday, the trade outlet Sportswear International estimated Brooks’ annual revenue reached roughly $1.6 billion in 2025, based on the company’s reported 16% sales increase and its prior growth trajectory.
The report estimated Brooks grew footwear revenue from approximately $1.23 billion in 2023 to $1.4 billion in 2024, before climbing again in 2025.
While Brooks remains more narrowly focused on performance running than global sportswear giants like Nike and Adidas, the report noted that its scale now places it among the biggest “pure running” brands in the world, competing more directly with fast-growing specialists like On and Hoka. (Which is not bad company to keep.)
Another Record-Breaking Year In 2026?
Sheridan said Brooks is entering 2026 with confidence after what the company described as a record year.
“Following a record 2025, we enter 2026 energized by the innovations and programs we’ll deliver to runners and retailers worldwide,” he said.
For Brooks, the financial results suggest the brand’s long-standing formula, focusing on a tight lineup of high-volume performance shoes and dominating specialty retail, is still paying off. And judging by the China numbers, it may be just getting started.
